12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Scancell preclinical data

In a mouse model of melanoma, Scancell's SCIB1 ImmunoBody vaccine in combination with Homspera from ImmuneRegen BioSciences Inc. (OTCBB:IRBS, Scottsdale, Ariz.) significantly improved the immune response to the...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >